Optimized dosing of cloxacillin in Staphylococcus aureus bacteremia (SAB) aiming to reduce mortality and morbidity – a pilot study to establish methods, markers for toxicity and a research network.
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.